Journal
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 40, Issue 4, Pages 540-552Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2006.01.015
Keywords
alpha(1A)-adrenergic receptor; fibrosis; matricellular; QRS amplitude
Categories
Funding
- NHLBI NIH HHS [HL 74161, HL 77860, HL 64639] Funding Source: Medline
Ask authors/readers for more resources
We previously reported that transgenic (TG) mice with cardiac-restricted alpha(1A)-adrenergic receptor (alpha(1A)-AR)-overexpression showed enhanced contractility, but no hypertrophy. Since chronic inotropic enhancement may be deleterious, we investigated if long-term, cardiac function and longevity are compromised. alpha(1A)-TG mice, but not their non-TG littermates (NTLs), showed progressive loss of left ventricular (LV) hypercontractility (dP/dt(max): 14,567 +/- 603 to 11,610 +/- 915 mmHg/s, P < 0.05, A1A1 line: 170-fold overexpression; and 13,625 +/- 826 to 8322 +/- 682 mmHg/s, respectively, P < 0.05, A1A4 line: 112-fold overexpression, at 2 and 6 months, respectively). Both TG lines developed LV fibrosis, but not LV dilatation or hypertrophy, despite activation of hypertrophic signaling pathways. Microarray and real time RT-PCR analyses revealed activation of matricellular protein genes, including those for thrombospondin 1, connective tissue growth factor and tenascin C, but not transforming growth factor beta 1. Life-span was markedly shortened (mean age at death: 155 days, A1A1 line; 224 days, A1A4 line compared with NTLs: > 300 days). Telemetric electrocardiography revealed that death in the a1A-AR TG mice was due to cardiac standstill preceded by a progressive diminution in QRS amplitude, but not by arrhythmias. The QRS changes and sudden death could be mimicked by alpha(1)-AR activation, and reversed preterminally by alpha(1)-AR blockade, suggesting a relationship to stress- or activity-associated catecholamine release. Thus, long-term augmentation of cardiac alpha(1A)-adrenergic drive leads to premature death and progressive LV fibrosis with reactivation of matricellular protein genes. To our knowledge this is the first evidence in vivo for a role of the (alpha(1A)-AR in ventricular fibrosis and in pathological cardiac remodeling. (c) 2006 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available